Highlights and Quick Summary
- Average Receivables for the quarter ending March 31, 2023 was $537 Thousand (a -12.33% decrease compared to previous quarter)
- Year-over-year quarterly Average Receivables increased by 40.03%
- Annual Average Receivables for 2022 was $613 Thousand (a 920.83% increase from previous year)
- Annual Average Receivables for 2021 was $60 Thousand (a 0.0% decrease from previous year)
Visit stockrow.com/DSGN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Average Receivables of Design Therapeutics, Inc.
Most recent Average Receivablesof DSGN including historical data for past 10 years.Interactive Chart of Average Receivables of Design Therapeutics, Inc.
Design Therapeutics, Inc. Average Receivables for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $0.54 | – | – | – | – |
| 2022 | $0.61 | $0.4 | $0.38 | $0.06 | $0.61 |
| 2021 | – | – | – | – | $0.06 |
| 2020 | – | – | – | – | $0.06 |
Business Profile of Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology